h2o Therapeutics, a digital health start-up, has partnered with AmerisourceBergen, a global healthcare company, to bring Parky to the market – a revolutionary prescription mobile app cleared by the FDA for monitoring symptoms in adults with Parkinson’s Disease. This revolutionary app provides users with unprecedented insight into their condition and the ability to actively manage their health.
The revolutionary Parky app is changing the way patients with movement disorders are monitored. Using Apple Inc.’s Apple Watch, the app is able to track tremors, dyskinesia and other symptoms in real-time, providing meaningful and reliable data to patients and medical professionals.
As part of a pilot program, AmerisourceBergen has joined forces with Parky to offer DTx Connect, a solution for patient engagement and health system integration. With Parky, patients with movement disorders can now stay connected to their healthcare in a whole new way.
As we mark Parkinson’s Awareness Month, h2o Therapeutics is proud to launch its patient-oriented technology, following the recent FDA clearance. Through a strategic arrangement with AmerisourceBergen, we are striving to reduce barriers along the patient journey, improve access and expand our commercial reach, in order to expand patient access to Parky. We are committed to helping make a difference in the lives of those affected by Parkinson’s Disease.
At AmerisourceBergen, we are excited to support h2o Therapeutics’ innovative digital therapeutics initiative to improve market access and product potential. With our digital health capabilities, we can help patients start on the Parky app quickly and easily following a prescription. We are proud to be part of this journey and look forward to the positive impact it will have on healthcare.
The Parky App is revolutionizing the way healthcare providers treat Parkinson’s Disease, the fastest-growing neurological disorder that affects over 10 million people worldwide. By providing healthcare providers with a real-time view of their patients’ daily lives, they are empowered to provide more personalized care. In the U.S. alone, this disease affects approximately one million people, and the Parky App is playing a critical role in helping to bridge the gap between in-clinic and real-life settings.
AmerisourceBergen is taking the lead in supporting digital therapeutics (DTx) developers and biopharmaceutical companies in their commercialization journey. With the launch of DTx Connect in 2022, the cloud-based, integrated ordering, dispensing and fulfillment platform promises to simplify patient access to physician-ordered digital therapeutics and digital diagnostics.
In addition to this, the company offers a range of services such as market access consulting, distribution and patient support services.
This Parkinson’s Awareness Month, AmerisourceBergen stands in solidarity with Parkinson’s Disease patients, their families, healthcare providers, and digital health innovators like h2o Therapeutics to ensure the highest quality of patient care.
We are honored to be part of this movement and are proud to be supporting the development of new and innovative medical treatments. Together, we can make a difference.
About h2o Therapeutics
h2o Therapeutics is developing innovative digital therapeutics that leverage the power of AI, robust clinical research, and high user engagement. Our focus is on wearable technologies, Augmented Reality (AR), and Artificial Intelligence (AI). Our mission is to use real-time human data to help people manage diseases better.
We are proud to announce that Parky, our prescription mobile app for Parkinson’s Disease, has recently been granted FDA clearance in 2022. With h2o Therapeutics, you can rest assured that your health is in the best of hands.
About AmerisourceBergen
AmerisourceBergen is more than just a leading global pharmaceutical solutions organization. We are dedicated to making a positive impact on the lives of people and animals around the world. By partnering with innovators across the value chain, we strive to ensure market access to the treatments that matter most.
Our 44,000+ team members are united in their mission to create healthier futures. Ranked #10 on the Fortune 500 and #21 on the Global Fortune 500, our success is fueled by over $200 billion in annual revenue. Together, we are revolutionizing the healthcare industry and creating brighter futures for all.